Severe Acute Respiratory Syndrome in Children

Lauren J. Stockman, MPH*†; Mehran S. Massoudi, PhD, MPH*; Rita Helfand, MD*; Dean Erdman, DrPH*; Alison M. Siwek, MPH*†; Larry J. Anderson, MD*; Umesh D. Parashar, MD, MPH*

Disclosures

Pediatr Infect Dis J. 2007;26(1):68-74. 

In This Article

Limitations

Some important caveats should be noted in interpretation of the findings of this review. First, we have summarized a variety of data collected by investigators in different countries without use of standardized data collection instruments, methods of assessment and management of patients, and diagnostic case definitions. Without consistent laboratory confirmation, these descriptions are likely to include cases that were not caused by SARS-CoV. Second, steroids and antiviral agents were used widely as empiric treatments for SARS in both adults and children. Although the effectiveness of these therapies is unknown, as a result of their use, many observed parameters such as biochemical levels and time required for chest radiograph resolution during the course of illness may not reflect the true natural history of SARS. We limited this review to English publications to allow us to review each case series consistently. However, experience with pediatric SARS appears to be similar across affected countries and is likely reflected by what has been published in the English literature.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....